Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES Share Price    (DIVI)

Here is the latest stock price and chart of Divis Laboratories. For more details, see the Divis Laboratories company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since large caps interest you, here's our guide to buying bluechip stocks.

REVEALED: Details of 3 "Super Smallcap" Stocks Nobody Tells You About...

REFRESH
Live BSE Quotes Sep 17, 2021 (Close)
Price (Rs)5,125.65 Open (Rs) 5,170.00 High (Rs) 5,197.95 Low (Rs) 5,064.65
% Change-0.74 Volume 7,652 Value (Rs) 39,382,600 52-Week H/L 5,269.00 / 2,986.70
Live NSE Quotes Sep 17, 2021 (Close)
Price (Rs)5,122.80 Open (Rs) 5,178.00 High (Rs) 5,198.65 Low (Rs) 5,059.55
% Change-0.85 Volume 401,270 Value (Rs) 2,062,274,222 52-Week H/L 5,271.65 / 2,985.00
Change
1 Day
-0.74%
1 Month
4.43%
3 Months
19.17%
1 Year
59.62%
5 Years (CAGR)*
30.76%
10 Years (CAGR)*
30.33%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 77.20 P/E Ratio (x) 66.40 Market Cap (Rs m) 1,360,699.13 P/BV (x) 14.64 Dividend Yield (%) 0.39
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

DIVIS LABORATORIES Share Price Today:

DIVIS LABORATORIES last traded price was down 0.7% to Rs 5,125.7 on the BSE. On the NSE, DIVIS LABORATORIES last traded price was down 0.9% to Rs 5,122.8. The total volume of shares traded was 0.4 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 1.1%. And the benchmark S&P BSE SENSEX was at 59,015.9 (down 0.2%).

Over the last 30 days, the DIVIS LABORATORIES share price is up 4.6%. And over the last one year, DIVIS LABORATORIES share price is up 58.0%.

The current market capitalisation of DIVIS LABORATORIES stands at Rs 1,360,699.13 m. For more information, check out the list of top 100 companies in India in terms of market cap.

As of June 2021, company promoters held 51.95% stake in DIVIS LABORATORIES, with no shares having been pledged. To know more, check out the latest shareholding pattern of DIVIS LABORATORIES.


What else is happening in the markets today? Dig in...


Today's Market

Sensex Slumps 700 Points from Day's High to End Lower; Tata Steel & SBI Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views On News

DIVIS LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Aug 12, 2021 | Updated on Aug 12, 2021

Here's an analysis of the annual report of DIVIS LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.2% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, DIVIS LABORATORIES has posted a net profit of Rs 6 bn (up 13.2% YoY). Sales on the other hand came in at Rs 20 bn (up 13.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 29.3% (Quarterly Result Update)

Jun 28, 2021 | Updated on Jun 28, 2021

For the quarter ended March 2021, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 29.3% YoY). Sales on the other hand came in at Rs 18 bn (up 28.7% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider (Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore (Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market (Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race (Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

Revenge Travel is Here. 9 Stocks Likely to Benefit (Views On News)

Sep 4, 2021

The term 'revenge travel' refers to the desire of going on a vacation after an extended period of lockdown.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - MYLAN COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS